A survey of drug-resistant Mycobacterium tuberculosis and its relationship to HIV infection

Keyphrases

• HIV Patients 100%
• HIV Infection 100%
• Drug Resistance 100%
• Drug-resistant Mycobacterium Tuberculosis 100%
• Multidrug-resistant Tuberculosis (MDR-TB) 66%
• Tuberculosis Patients 66%
• Acquired Drug Resistance 66%
• Drug Susceptibility 66%
• HIV-negative Patients 66%
• Tuberculosis 33%
• Ethambutol 33%
• Rifampin 33%
• Tuberculosis Control 33%
• Directly Observed Therapy 33%
• Rifabutin 33%
• Risk Factors 33%
• HIV Status 33%
• Patient Assessment 33%
• Acquired Resistance 33%
• Public Health Departments 33%
• Tuberculosis Disease 33%
• HIV-positive 33%
• Serological Test 33%
• Prospective Evaluation 33%
• Kanamycin 33%
• Capreomycin 33%
• Outpatient Management 33%
• Streptomycin 33%
• HIV-negative 33%
• Ethionamide 33%
• Initial Resistance 33%
• Historical Prospective 33%

Medicine and Dentistry

• Human Immunodeficiency Virus 100%
• Human Immunodeficiency Virus Infection 100%
• Mycobacterium Tuberculosis 100%
• Drug Resistance 50%
• Drug Resistant Tuberculosis 20%
• Drug Sensitivity 20%
• Ethambutol 10%
• Directly Observed Therapy 10%
• Isoniazid Plus Rifampicin 10%
• Disease 10%
• Prevalence 10%
• Outpatient 10%
• Public Health 10%
• Capreomycin 10%
• Kanamycin 10%
• Rifabutin 10%
• Streptomycin 10%
• Ethionamide 10%